Delivery Order SPE2DB20D1004-SPE2DB22FF1A3
Award Date 1/11/22
Potential Completion Date 2/2/22
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of 61 mg VYNDAMAX capsules. The contract has a firm fixed price of $12,960.30 and a completion date of September 18, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to...
- This is a $12,960.30 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, by the Defense Logistics Agency (DLA) for the supply of the drug VYNDAMAX 61 MG CAPSULE UD 30S. The contract has an ultimate completion date of May 7, 2024. Amerisourcebergen Drug Corp is the Corporate Office Division of the parent company Cencora, Inc., which does business as Amerisourcebergen. This delivery order is part of a larger Indefinite...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $12,345.34 contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty pharmaceutical product. The order has a completion date of February 23, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 from DLA to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $24,690.70 award is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves...
- The U.S. Department of Defense, Medical Supply Chain awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution services company. The contract, valued at $49,381.36, is for the provision of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty pharmaceutical product. This delivery order is likely part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with...
- The Defense Logistics Agency (DLA) awarded a $12,345.34 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of VYNDAMAX 61 MG CAPSULE UD 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Vyndamax 61 MG Capsule UD 30S, a pharmaceutical product, with a ceiling value of $27,693.94 and a completion date of July 7, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, a for-profit organization based in...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999. The contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, to support military treatment programs and facilities worldwide. The delivery order has a firm fixed price of $12,960.30 and a period of performance through November 1, 2024. The contract does not have a set-aside designation....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,846.97 firm-fixed-price contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The contract has an ultimate completion date of July 15, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for $69,234.85 and covers the supply of the medication VYNDAMAX 61 MG CAPSULE UD 30S. The contract is a firm fixed-price agreement, has an ultimate completion date of July 25, 2025, and is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...